Skip to main content
Livermore
Livermore
ZHEN

Fairfield, Bush & Co.

SEC CIK
0001116247
Latest filing
Aug 13, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Fairfield, Bush & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
18,073
Value
$866.4K
% of portfolio
0.4%
Quarters held
22
Since Q1 2021
Holdings of NVO by Fairfield, Bush & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,073$866.4K0.4%+1,977+12.3%AddedHolders
Q1 202616,096$591.5K0.3%−1,718−9.6%ReducedHolders
Q4 202517,814$906.4K0.5%+284+1.6%AddedHolders
Q3 202517,530$972.7K0.5%+321+1.9%AddedHolders
Q2 202517,209$1.19M0.7%+186+1.1%AddedHolders
Q1 202517,023$1.18M0.7%+1,299+8.3%AddedHolders
Q4 202415,724$1.35M0.8%−2,760−14.9%ReducedHolders
Q3 202418,484$2.20M1.3%+2,304+14.2%AddedHolders
Q2 202416,180$2.31M1.4%+718+4.6%AddedHolders
Q1 202415,462$1.99M1.2%+1,655+12.0%AddedHolders
Q4 202313,807$1.43M0.8%+8,315+151.4%AddedHolders
Q3 20235,492$499.4K0.3%−4,000−42.1%ReducedConverted for a 2-for-1 splitHolders
Q2 20234,746$768.0K0.2%−23,000−82.9%ReducedHolders
Q1 202327,746$4.42M1.6%+24,750+826.1%AddedHolders
Q4 20222,996$405.5K0.3%−200−6.3%ReducedHolders
Q3 20223,196$318.0K0.2%00.0%UnchangedHolders
Q2 20223,196$356.0K0.2%00.0%UnchangedHolders
Q1 20223,196$355.0K0.2%00.0%UnchangedHolders
Q4 20213,196$358.0K0.2%−25,100−88.7%ReducedHolders
Q3 202128,296$2.72M0.9%00.0%UnchangedHolders
Q2 202128,296$2.37M0.6%−700−2.4%ReducedHolders
Q1 202128,996$1.96M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.